Skip to main content

Antigen Presentation Assays to Investigate Uncharacterized Immunoregulatory Genes

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 890))

Abstract

Antigen presentation to T lymphocytes is the seminal triggering event of the specific immune response, and poxviruses encode immunomodulatory genes that disrupt this process. Discovery of viral proteins that interfere with steps in the antigen presentation process requires a robust, easily manipulated antigen-presenting and T lymphocyte response system. Use of fresh primary antigen-presenting cells (APC) is preferable because cell lines that can present antigen in vitro are often not representative of APC in vivo and are typically weak stimulators. To study immunomodulatory poxvirus genes, we have used infected primary rat macrophages to present a model antigen, the myelin basic protein peptide, to a cognate CD4+ RsL11 T cell clone. Using this system, viruses can be assessed for difference in immunomodulation, and viral gene functions may also be assayed by comparing effects of wild type virus and mutant viruses (e.g., a deletion in the putative immunomodulatory gene). While antigen presentation can be thought of as a single event, it can also be considered as a larger process comprising multiple steps including: antigen acquisition, antigen processing, peptide loading onto MHC molecules, transport to the surface, MHC binding to T cell receptor, interaction of costimulatory molecules, cell signaling, cytokine synthesis by both cells, and proliferation of antigen specific T lymphocytes. This system allows for the initial determination of whether there is a phenotype and then also allows the stepwise deconstruction of the system to analyze this process at several points to focus in on the mechanism of immunomodulation. We have used this model system to elucidate the function of a highly conserved but previously uncharacterized poxvirus gene that we showed was important for virulence in rodents. The experimental system developed should be broadly applicable to analyzing viral effects on immunity.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Upton C, Slack S, Hunter AL, Ehlers A, Roper RL (2003) Poxvirus orthologous cluster: toward defining the minimum essential poxvirus genome. J Virol 77:7590–7600

    Article  PubMed  CAS  Google Scholar 

  2. Ludwig H, Mages J, Staib C, Lehmann MH, Lang R, Sutter G (2005) Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa cells: regulation of the virus life cycle and identification of differentially expressed host genes. J Virol 79:2584–2596

    Article  PubMed  CAS  Google Scholar 

  3. Guo ZS, Naik A, O’Malley ME, Popovic P, Demarco R, Hu Y et al (2005) The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Res 65:9991–9998

    Article  PubMed  CAS  Google Scholar 

  4. Bradley RR, Terajima M (2005) Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein. Virus Res 114:104–112

    Article  PubMed  CAS  Google Scholar 

  5. Langland JO, Jacobs BL (2002) The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299:133–141

    Article  PubMed  CAS  Google Scholar 

  6. Johnston JB, Barrett JW, Nazarian SH, Goodwin M, Ricuttio D, Wang G et al (2005) A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23:587–598

    Article  PubMed  CAS  Google Scholar 

  7. Jackson SS, Ilyinskii P, Philippon V, Gritz L, Yafal AG, Zinnack K et al (2005) Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. J Virol 79:6554–6559

    Article  PubMed  CAS  Google Scholar 

  8. Rehm KE, Connor RF, Jones GJB, Yimbu K, Mannie MD, Roper RL (2009) Vaccinia virus decreases MHC class II antigen presentation, T cell priming, and peptide association with MHC class II. Immunology 128:381–392

    Article  PubMed  CAS  Google Scholar 

  9. Rehm KE, Jones GJ, Tripp AA, Metcalf MW, Roper RL (2010) The poxvirus A35 protein is an immunoregulator. J Virol 84:418–425

    Article  PubMed  CAS  Google Scholar 

  10. Stewart TL, Wasilenko ST, Barry M (2005) Vaccinia virus F1L protein is a tail-anchored protein that functions at the mitochondria to inhibit apoptosis. J Virol 79:1084–1098

    Article  PubMed  CAS  Google Scholar 

  11. Gomez CE, Vandermeeren AM, Garcia MA, Domingo-Gil E, Esteban M (2005) Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinant. Virol J 2:81

    Article  PubMed  Google Scholar 

  12. Wang G, Barrett JW, Nazarian SH, Everett H, Gao X, Bleackley C et al (2004) Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J Virol 78:7097–7111

    Article  PubMed  CAS  Google Scholar 

  13. Roper RL, Payne LG, Moss B (1996) Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene. J Virol 70:3753–3762

    PubMed  CAS  Google Scholar 

  14. Roper RL, Wolffe EJ, Weisberg A, Moss B (1998) The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J Virol 72:4192–4204

    PubMed  CAS  Google Scholar 

  15. Nichols DB, Shisler JL (2006) The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation. J Virol 80:578–586

    Article  PubMed  CAS  Google Scholar 

  16. Shisler JL, Jin XL (2004) The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol 78:3553–3560

    Article  PubMed  CAS  Google Scholar 

  17. Guerra S, Lopez-Fernandez LA, Conde R, Pascual-Montano A, Harshman K, Esteban M (2004) Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. J Virol 78:5820–5834

    Article  PubMed  CAS  Google Scholar 

  18. Rubins KH, Hensley LE, Jahrling PB, Whitney AR, Geisbert TW, Huggins JW et al (2004) The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci USA 101:15190–15195

    Article  PubMed  CAS  Google Scholar 

  19. Wyatt LS, Earl PL, Eller LA, Moss B (2004) Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci USA 101:4590–4595

    Article  PubMed  CAS  Google Scholar 

  20. Roper RL (2006) Characterization of the vaccinia virus A35R protein and its role in virulence. J Virol 80:306–313

    Article  PubMed  CAS  Google Scholar 

  21. Martina BE, van Doornum G, Dorrestein GM, Niesters HG, Stittelaar KJ, Wolters MA et al (2006) Cowpox virus transmission from rats to monkeys, the Netherlands. Emerg Infect Dis 12:1005–1007

    Article  PubMed  Google Scholar 

  22. Rehm KE, Connor RF, Jones GJ, Yimbu K, Roper RL (2010) Vaccinia virus A35R inhibits MHC class II antigen presentation. Virology 397:176–186

    Article  PubMed  CAS  Google Scholar 

  23. Mannie MD, Dawkins JG, Walker MR, Clayson BA, Patel DM (2004) MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals. Cell Immunol 230:33–43

    Article  PubMed  CAS  Google Scholar 

  24. Mannie MD, Norris MS (2001) MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4-responders. Cell Immunol 212:51–62

    Article  PubMed  CAS  Google Scholar 

  25. Campos-Neto A, Ovendale P, Bement T, Koppi TA, Fanslow WC, Rossi MA et al (1998) CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 160:2037–2041

    PubMed  CAS  Google Scholar 

  26. Li P, Wang N, Zhou D, Yee CS, Chang CH, Brutkiewicz RR et al (2005) Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J Immunol 175:6481–6488

    PubMed  CAS  Google Scholar 

  27. Chahroudi A, Chavan R, Koyzr N, Waller EK, Silvestri G, Feinberg MB (2005) Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J Virol 79:10397–10407

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The author wishes to thank Dr. Mark Mannie, East Carolina University, for developing the rat antigen presentation system and for his generous help and advice. This work was supported by The North Carolina Biotechnology Center and NIH grant U54 AI057157 from Southeast Regional Center of Excellence for Emerging Infections and Biodefense.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rachel L. Roper .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Roper, R.L. (2012). Antigen Presentation Assays to Investigate Uncharacterized Immunoregulatory Genes. In: Isaacs, S. (eds) Vaccinia Virus and Poxvirology. Methods in Molecular Biology, vol 890. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-876-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-876-4_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-875-7

  • Online ISBN: 978-1-61779-876-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics